Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Changing incidence and improved survival of gliomas.
Ho VK, Reijneveld JC, Enting RH, Bienfait HP, Robe P, Baumert BG, Visser O; Dutch Society for Neuro-Oncology (LWNO). Ho VK, et al. Among authors: reijneveld jc. Eur J Cancer. 2014 Sep;50(13):2309-18. doi: 10.1016/j.ejca.2014.05.019. Epub 2014 Jun 24. Eur J Cancer. 2014. PMID: 24972545
Decision-making in the end-of-life phase of high-grade glioma patients.
Sizoo EM, Pasman HR, Buttolo J, Heimans JJ, Klein M, Deliens L, Reijneveld JC, Taphoorn MJ. Sizoo EM, et al. Among authors: reijneveld jc. Eur J Cancer. 2012 Jan;48(2):226-32. doi: 10.1016/j.ejca.2011.11.010. Epub 2011 Dec 5. Eur J Cancer. 2012. PMID: 22153216 Free article.
Trial design on prophylaxis and treatment of brain metastases: lessons learned from the EORTC Brain Metastases Strategic Meeting 2012.
Preusser M, Winkler F, Collette L, Haller S, Marreaud S, Soffietti R, Klein M, Reijneveld JC, Tonn JC, Baumert BG, Mulvenna P, Schadendorf D, Duchnowska R, Berghoff AS, Lin N, Cameron DA, Belkacemi Y, Jassem J, Weber DC. Preusser M, et al. Among authors: reijneveld jc. Eur J Cancer. 2012 Dec;48(18):3439-47. doi: 10.1016/j.ejca.2012.07.002. Epub 2012 Aug 8. Eur J Cancer. 2012. PMID: 22883982
Genetics and pharmacogenomics of diffuse gliomas.
van Thuijl HF, Ylstra B, Würdinger T, van Nieuwenhuizen D, Heimans JJ, Wesseling P, Reijneveld JC. van Thuijl HF, et al. Among authors: reijneveld jc. Pharmacol Ther. 2013 Jan;137(1):78-88. doi: 10.1016/j.pharmthera.2012.09.002. Epub 2012 Sep 14. Pharmacol Ther. 2013. PMID: 22985521 Review.
Health-related quality of life and cognitive functioning in long-term anaplastic oligodendroglioma and oligoastrocytoma survivors.
Habets EJ, Taphoorn MJ, Nederend S, Klein M, Delgadillo D, Hoang-Xuan K, Bottomley A, Allgeier A, Seute T, Gijtenbeek AM, de Gans J, Enting RH, Tijssen CC, van den Bent MJ, Reijneveld JC. Habets EJ, et al. Among authors: reijneveld jc. J Neurooncol. 2014 Jan;116(1):161-8. doi: 10.1007/s11060-013-1278-0. Epub 2013 Oct 26. J Neurooncol. 2014. PMID: 24162809
The level of patient-reported outcome reporting in randomised controlled trials of brain tumour patients: a systematic review.
Dirven L, Taphoorn MJ, Reijneveld JC, Blazeby J, Jacobs M, Pusic A, La Sala E, Stupp R, Fayers P, Efficace F; EORTC Quality of Life Group (Patient Reported Outcome Measurements Over Time In ONcology-PROMOTION Registry). Dirven L, et al. Among authors: reijneveld jc. Eur J Cancer. 2014 Sep;50(14):2432-48. doi: 10.1016/j.ejca.2014.06.016. Epub 2014 Jul 14. Eur J Cancer. 2014. PMID: 25034656 Review.
The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: results of the randomised controlled phase 2 BELOB trial.
Dirven L, van den Bent MJ, Bottomley A, van der Meer N, van der Holt B, Vos MJ, Walenkamp AM, Beerepoot LV, Hanse MC, Reijneveld JC, Otten A, de Vos FY, Smits M, Bromberg JE, Taal W, Taphoorn MJ; Dutch Neuro-Oncology Group (LWNO). Dirven L, et al. Among authors: reijneveld jc. Eur J Cancer. 2015 Jul;51(10):1321-30. doi: 10.1016/j.ejca.2015.03.025. Epub 2015 Apr 17. Eur J Cancer. 2015. PMID: 25899986 Clinical Trial.
Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.
Reijneveld JC, Taphoorn MJB, Coens C, Bromberg JEC, Mason WP, Hoang-Xuan K, Ryan G, Hassel MB, Enting RH, Brandes AA, Wick A, Chinot O, Reni M, Kantor G, Thiessen B, Klein M, Verger E, Borchers C, Hau P, Back M, Smits A, Golfinopoulos V, Gorlia T, Bottomley A, Stupp R, Baumert BG. Reijneveld JC, et al. Lancet Oncol. 2016 Nov;17(11):1533-1542. doi: 10.1016/S1470-2045(16)30305-9. Epub 2016 Sep 27. Lancet Oncol. 2016. PMID: 27686943 Clinical Trial.
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.
Baumert BG, Hegi ME, van den Bent MJ, von Deimling A, Gorlia T, Hoang-Xuan K, Brandes AA, Kantor G, Taphoorn MJB, Hassel MB, Hartmann C, Ryan G, Capper D, Kros JM, Kurscheid S, Wick W, Enting R, Reni M, Thiessen B, Dhermain F, Bromberg JE, Feuvret L, Reijneveld JC, Chinot O, Gijtenbeek JMM, Rossiter JP, Dif N, Balana C, Bravo-Marques J, Clement PM, Marosi C, Tzuk-Shina T, Nordal RA, Rees J, Lacombe D, Mason WP, Stupp R. Baumert BG, et al. Among authors: reijneveld jc. Lancet Oncol. 2016 Nov;17(11):1521-1532. doi: 10.1016/S1470-2045(16)30313-8. Epub 2016 Sep 27. Lancet Oncol. 2016. PMID: 27686946 Free PMC article. Clinical Trial.
230 results